Pleural Mesothelioma Rates Expected to Decline Just as Lung Cancer Deaths Have

pleural mesothelioma rates

A new report suggests that pleural mesothelioma rates will continue to decline worldwide over the next decade as many countries get wise to the dangers of asbestos. The report comes on the heels of another study showing dramatic declines in US lung cancer deaths.  The report on mesothelioma rates comes from market research website, Research and Markets. The company evaluated malignant pleural mesothelioma incidence in seven countries to come up with an 11-year forecast. According to the research, the US, UK, Japan, and four European countries can expect declining rates of asbestos cancer through 2030. Those who do receive a pleural mesothelioma diagnosis may benefit from some of the same drugs that are helping lung cancer patients survive. Lung Cancer … Continue reading Pleural Mesothelioma Rates Expected to Decline Just as Lung Cancer Deaths Have »

COPD Drug Might Help with Drooling in Pleural Mesothelioma Patients

A UK doctor says a drug used to treat COPD can help with drooling in pleural mesothelioma patients on palliative care.  Dr. Claire Plunkett recently published the case report of a mesothelioma patient receiving palliative care. The patient developed a problem with drooling and swallowing. The medical term for drooling is sialorrhoea. It can happen in people with certain conditions or on certain drugs. Doctors at Farleigh Hospice in Chelmsford, UK treated the man with a glycopyrronium bromide inhaler. Glycopyrronium is normally used for patients with chronic obstructive pulmonary disorder (COPD).  The treatment cured the problem in just a few days. Plunkett says this is evidence that glycopyrronium is a good option to treat drooling in pleural mesothelioma patients. What … Continue reading COPD Drug Might Help with Drooling in Pleural Mesothelioma Patients »

Common Drugs May Impact Mesothelioma Survival After Immunotherapy

There is new evidence that taking certain common drugs could negatively impact mesothelioma survival after immunotherapy.  Drugs such as NSAIDs, antacids, corticosteroids, and antibiotics affect the microbiome. The microbiome is the collection of bacteria that live in a person’s gut.  The microbiome interacts with the immune system. Ohio State University researchers say some medicines disrupt the microbiome. This can threaten the effectiveness of cancer immunotherapy.  The Microbiome and Immunity The microbiome is the collection of bacteria that live in the intestinal tract. Every mesothelioma patient’s microbiome is unique. Scientists are just beginning to understand the importance of the microbiome in human health.  At first glance, there might not seem to be a direct correlation between the microbiome and mesothelioma survival … Continue reading Common Drugs May Impact Mesothelioma Survival After Immunotherapy »

Pleural Effusion in Mesothelioma: Comparing Solutions

pleural effusion in mesothelioma

A new study says, when it comes to pleural effusion in mesothelioma, the two main solutions are pretty equal – with one exception.  Pleural effusion is a buildup of fluid in the space around the lungs. Over time, this fluid restricts the lungs and makes it hard to breathe. The problem is common in several types of cancer, including malignant mesothelioma.  In a new report, Taiwanese and Hong Kong researchers compared the two primary ways of dealing with pleural effusion in mesothelioma. They conclude that the two methods work equally well. But one of them usually means a longer hospital stay. Understanding Pleural Effusion in Mesothelioma The pleura are layers of thin membranes that surround the lungs. Pleural mesothelioma tumors … Continue reading Pleural Effusion in Mesothelioma: Comparing Solutions »

Herb-like Compound May Be Alternative Treatment for Mesothelioma

alternative treatment for mesothelioma

A man-made version of a traditional Chinese herb could be an alternative treatment for mesothelioma.  Turkish researchers have published a new study on a drug called halofuginone. The study shows the drug has significant anticancer effects on mesothelioma cells.  In an article in Cell Biology International, they explore how halofuginone affects mesothelioma and lung cancer cells.  Mesothelioma Patients Need Another Treatment Option Mesothelioma is an asbestos-linked cancer that is hard to treat. Pleural mesothelioma is the most common type. Pleural mesothelioma grows quickly. It usually causes few symptoms until it is very advanced.  Chemotherapy is the main treatment. When that stops working, many patients look for an alternative treatment for mesothelioma.  Scientists are studying immunotherapy, new kinds of radiotherapy, and … Continue reading Herb-like Compound May Be Alternative Treatment for Mesothelioma »

Familial and Environmental Asbestos Exposure Raise Mesothelioma Risk in Women

environmental asbestos exposure

Italian researchers say women who live around an asbestos plant or with one of its workers may be at special risk for mesothelioma from the combination of familial and environmental asbestos exposure.  The research appears in a new issue of the Annals of Work Exposures and Health.  Scientists have long known about the link between asbestos on worker’s clothes and mesothelioma among the women who wash those clothes.  But the new report shows that some of these women face an even greater cumulative risk because of environmental asbestos exposure. Bringing the Mesothelioma Risk Home Traditionally, most jobs with the potential for asbestos exposure have been in male-dominated industries. These include industries like construction, shipbuilding, plumbing, electrical work, and asbestos mining … Continue reading Familial and Environmental Asbestos Exposure Raise Mesothelioma Risk in Women »

Mesothelioma in Women: Study Reveals Diagnostic Trends

mesothelioma in women

A major study of mesothelioma in women finds that women tend to contract the disease earlier in life than men do. The analysis included 354 cases of malignant mesothelioma from a database of more than 2,800.  While the average age for pleural mesothelioma diagnosis is 72, the average age for women to be diagnosed with any type of mesothelioma was just 60. It could mean that the latency period for mesothelioma is shorter for women than it is in men. It could also mean that women are more attuned to mesothelioma symptoms and recognize the disease sooner.  Mesothelioma’s Long Latency  The latency period is the time between exposure to a cancer-causing agent and the occurrence of cancer. Mesothelioma has one … Continue reading Mesothelioma in Women: Study Reveals Diagnostic Trends »

Video-Assisted Pleural Biopsy for Mesothelioma is Not Always Accurate

video-assisted pleural biopsy

New research shows some patients are more likely to get an accurate mesothelioma diagnosis from video-assisted pleural biopsy than others.  Cancer doctors at Japan’s Hyogo College of Medicine conducted the new research. It included four hundred patients with suspected pleural mesothelioma.   The researchers found that certain conditions can affect the accuracy of video-assisted pleural biopsy. Patients with early stage mesothelioma, a lot of inflammation, or fibrous connective tissue around their tumors were more likely to be misdiagnosed. Biopsy for Mesothelioma Diagnosis VATS is the acronym for video-assisted thoracoscopic surgery. It is a minimally-invasive surgical technique to diagnose problems in the chest. Mesothelioma tumors grow on the membrane around the lungs (pleura). Doctors may use the video-assisted pleural biopsy technique … Continue reading Video-Assisted Pleural Biopsy for Mesothelioma is Not Always Accurate »

Multidisciplinary Care for Mesothelioma

multidisciplinary care for mesothelioma

Italian doctors say patients are more likely to enter clinical trials when they have multidisciplinary care for mesothelioma.  Inclusion in clinical trials is one of the best ways for mesothelioma patients to access cutting edge treatments.  The study shows multidisciplinary care for mesothelioma helps funnel patients into trials. It  also provides better monitoring of treatment response and better access to palliative care.  What is the Multidisciplinary Approach? In most hospitals, mesothelioma patients receive diagnosis from a cancer doctor or oncologist. The oncologist orders the appropriate diagnostic tests and helps craft the treatment plan. Diagnostic imaging or radiotherapy for mesothelioma is usually overseen by radiology specialists. But multidisciplinary care for mesothelioma involves a bigger team of people. The team consists of … Continue reading Multidisciplinary Care for Mesothelioma »

Asbestos and Lung Cancer: Study Highlights the Link

asbestos and lung cancer

A new report on asbestos and lung cancer says asbestos could be to blame for the cancer, even if the patient is a heavy smoker.  In smokers, lung cancer is usually attributed to tobacco use. But cancer researchers in Australia and Finland say that is not always right, especially if the patient has been exposed to asbestos. They propose new criteria for establishing the cause of lung cancer in asbestos-exposed people. The criteria would apply to both smokers and non-smokers. Mesothelioma is Not the Only Cancer Linked to Exposure Malignant mesothelioma is the cancer most often associated with asbestos exposure.  Mesothelioma is a rare but fast-growing and treatment-resistant cancer. Asbestos exposure is the only known cause of mesothelioma. Smoking increases … Continue reading Asbestos and Lung Cancer: Study Highlights the Link »

Get your free copy of
“Surviving Mesothelioma” Today!